AN ACT Relating to protecting consumers by removing barriers created by medical debt;
HB 1632 is a consumer-protection bill focused on medical debt and debt collection practices. It amends Washington’s debt collection statutes to define “medical debt” broadly, covering obligations arising from health care services and certain medical products and devices, and it adds a new section making medical debt void and unenforceable if a health care provider, facility, or licensed collection agency violates the bill’s disclosure and reporting restrictions. The bill also prohibits contracts for medical debt that omit required terms and bars holders of medical debt from furnishing information about that debt to consumer credit reporting agencies.
The bill imposes new notice and itemization requirements for medical debt collection. For first notices, collectors must provide information such as the original account number, date of last payment, itemized charges, adjustments, payments, and whether the patient was eligible for charity care or other reductions. It also requires hospitals to notify patients about possible charity care eligibility and restricts collection activity while charity care applications or appeals are pending once notice is received. In addition, hospitals must provide patients with a written list of physician groups and other professional partners that may bill separately, and those groups are likewise barred from reporting medical debt to credit bureaus.
HB 1632 also changes consumer reporting law by adding medical debt to the list of adverse items that generally may not appear on consumer reports after seven years, while preserving existing exceptions for certain large credit transactions, life insurance underwriting, and employment screening. The bill further limits what hospitals and related providers may say or do in connection with medical debt, and it directs state agencies to administer the affected chapter through the Secretary of Health in specified areas. Overall, the bill would significantly tighten the rules governing how medical debt is billed, collected, reported, and enforced in Washington.
The general sentiment reflected by the bill text is strongly consumer-protective, with the legislature expressly finding that the covered practices are matters of public interest and that violations are unfair or deceptive under the Consumer Protection Act. Because no committee transcripts or votes were provided, there is no recorded debate or roll-call history here to indicate opposition or support from specific lawmakers. The structure and findings suggest the bill was designed to reduce surprise billing, limit credit harm from medical debt, and improve transparency for patients.
The main points of contention likely center on the bill’s restrictions on provider and collector conduct, especially the prohibition on reporting medical debt to credit bureaus, the requirement to stop collection efforts until itemized information is provided, and the provision voiding debts when the new rules are violated. Health care providers, hospitals, and collection agencies could view these provisions as burdensome or as limiting recovery tools, while consumer advocates would likely support them as necessary protections for patients facing medical bills.
The bill would amend Washington’s debt collection and consumer reporting laws to create a separate regulatory framework for medical debt. It would add definitions and restrictions in chapter 19.16 RCW, create a new unenforceability remedy for violations involving medical debt, and revise chapter 19.182 RCW to bar consumer reporting agencies from including medical debt in consumer reports after the applicable reporting period. It would also impose new disclosure, itemization, and charity-care notice duties on hospitals, health care providers, and licensed collection agencies, while limiting when and how medical debt may be collected or reported.
The bill’s tone is strongly pro-consumer and anti-medical-debt-harm. The statutory findings explicitly frame the regulated practices as matters of public interest and as unfair or deceptive acts under the Consumer Protection Act, indicating clear legislative support for stronger patient protections. No committee transcript or vote data were provided, so there is no documented floor or committee opposition in the supplied materials, but the bill’s design suggests it was intended to address widespread concern about medical debt burdens and credit damage.
The most likely areas of contention are the bill’s strict limits on collection and reporting, especially the ban on furnishing medical debt to consumer credit reporting agencies and the rule that violations can render the debt void and unenforceable. Hospitals, physician groups, and collection agencies may object that the bill increases compliance costs, delays collections, and reduces leverage to recover unpaid balances. Consumer advocates, by contrast, would likely support the bill’s transparency requirements, charity-care protections, and credit-reporting restrictions as necessary to prevent medical debt from becoming a barrier to care and financial stability.